[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$canta
Cantargia announces preliminary topline efficacy results from the Phase X TRIFOUR trial. Redeye provides commentary on the data and the company's future.
About $canta
Cantargia ($canta) is a biotechnology company.
Insights #
- $canta creators is up XXX% from the previous week.
- $canta mentions is up XXX% from the previous week.
- $canta Creators hit a high of XX for the day
- $canta Creators hit an all time of XX for the day
- $canta Mentions hit a high of XX for the day
- $canta Mentions hit an all time of XX for the day
- $canta Engagements hit a high of XXXXX for the day
- $canta Engagements hit an all time of XXXXX for the day
Engagements: XX #
Engagements 24-Hour Chart Data
Current Value: XX
Daily Average: XXX
1 Month: XXXXXX +415%
1-Year High: XXXXX on 2025-07-17
1-Year Low: X on 2025-05-09
| Social Network | X |
|---|---|
| Engagements | XX |
Mentions: X #
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Week: XX +525%
1 Month: XX +329%
1-Year High: XX on 2025-07-18
1-Year Low: X on 2025-04-27
| Social Network | X |
|---|---|
| Mentions | XX |
Creators: X #
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $canta in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: X
1 Week: XX +500%
1 Month: XX +333%
1-Year High: XX on 2025-07-18
1-Year Low: X on 2025-04-27
Sentiment: % #
Sentiment 24-Hour Chart Data
Current Value: %
Daily Average: XX%
1-Year High: XXX% on 2025-07-03
1-Year Low: XX% on 2025-07-20
Top topics mentioned In the posts about $canta in the last XX hours
$4768t, $4578t, $580m, $33m, acquisition, dag, transformative, abus, eps, $lenz, $ghrs, $fna, gns
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Redeye comments on the negative topline data in the TRIFOUR study and provides a new base case for Cantargia. $CANTA"
@Redeye_ on X 2025-07-18 07:00:17 UTC 14.5K followers, 1565 engagements
"$CANTA - Cantargia Announces Preliminary Topline Efficacy Results From the Phase X TRIFOUR Trial of Nadunolimab in Advanced Triple-Negative Breast Cancer (TNBC)"
@tenet_research on X 2025-07-17 19:45:55 UTC 452.5K followers, 1238 engagements
"The results in 2nd line non-squamous non-small cell lung cancer are very strong $CANTA #CANTARGIA"
@FrillePelle on X 2025-07-17 07:21:52 UTC XXX followers, XXX engagements
"Redeye provides a brief comment on the publication of an article in the journal Lung Cancer. $CANTA"
@Redeye_ on X 2025-07-17 07:09:28 UTC 14.5K followers, 2056 engagements